Immunology and Immunotherapy
A section of Biomedicines (ISSN 2227-9059).
Section Information
This section publishes reviews and original peer-reviewed papers of a high scientific level covering all the aspects of immunology and oncoImmunology. Papers aim to uncover the modulations of the immune system, active and passive immunotherapies, the diagnostic test based on specific markers and the use of new technologies to identify novel predictive factors to respond to immunotherapy. Topics include, but are not limited to in vivo/in vitro immune responses research; targeted therapies (including antibody research and vaccine research); virotherapy and oncolytic vaccines; use of nanoparticles and microvesicles for developing immunotherapeutics; etc.
Editorial Board
Topical Advisory Panel
Special Issues
Following special issues within this section are currently open for submissions:
- New Advances in the Role of Regulatory T Cells in Immunity (Deadline: 30 April 2024)
- Advances in Macrophage-Based Immunotherapy (Deadline: 30 April 2024)
- Signaling Networks and Gene Expression in Immune Cells (Deadline: 30 April 2024)
- Immunogenicities and Immunotherapies in Leukemia (Deadline: 30 April 2024)
- The Role of Alarmins in Human Pathologies: Impact on Diagnostic and Therapeutic Approaches (Deadline: 30 April 2024)
- Modulation of Anti-tumor Immunity and Tumor Microenvironment (Deadline: 30 April 2024)
- Oncolytic Viruses and Combinatorial Immunotherapy for Cancer (Deadline: 30 May 2024)
- Identification and Validation of New Biomarkers to Help the Creation of Clinical Diagnostics in Autoimmune and Cancer Diseases (Deadline: 31 May 2024)
- Acute and Chronic Urticaria: New Insights into Pathogenesis, Diagnosis and Therapy (Deadline: 31 May 2024)
- The End of the COVID-19 Pandemic—What Is Currently Known and What Could Have Been Useful Four Years Ago? (Deadline: 31 May 2024)
- Trained Immunity and Endotoxin Tolerance in Inflammatory Diseases (Deadline: 31 May 2024)
- COVID-19 Vaccination, Role of Vaccines and Global Health (Deadline: 31 May 2024)
- Interactions between Gut Microbiota and Immune System (Deadline: 31 May 2024)
- Editorial Board Members' Collection Series: Immunotherapy (Deadline: 31 May 2024)
- Allergic Diseases and Asthma: Molecular Diagnosis and Precision Medicine (Deadline: 31 May 2024)
- Autoimmune Diseases and Immune Modulation: Current Research and Future Outlook (Deadline: 31 May 2024)
- Stem Cells and Immunomodulation (Deadline: 31 May 2024)
- Gut Microbiota, Diet, and Immunity: Investigating the Connections and Implications for Disease Development (Deadline: 31 May 2024)
- Vitamin D in Health and Disease (3rd Edition) (Deadline: 30 June 2024)
- Basic and Clinical Researches of Antiphospholipid Syndrome: 2nd Edition (Deadline: 30 June 2024)
- Cellular Immune Responses in Diseases (Deadline: 30 June 2024)
- Current Molecular Research on Skin Diseases (Deadline: 30 June 2024)
- State-of-the-Art Immunology and Immunotherapy in Europe (2nd Edition) (Deadline: 30 June 2024)
- Recent Advances in Immunotherapy for Solid Tumors (Deadline: 30 June 2024)
- Immune Checkpoints and Autoimmunity — Volume II (Deadline: 31 July 2024)
- Immunometabolic Determinants of Gut–Liver Axis Health (Deadline: 31 July 2024)
- Periodontal Inflammation, Periodontal Disease and Systemic Diseases (Deadline: 31 July 2024)
- Inflammaging and Immunosenescence: Mechanisms and Link (Deadline: 31 July 2024)
- Inflammation and Immunosenescence in Age-Related Diseases (Deadline: 31 July 2024)
- Crohn's Disease and Ulcerative Colitis: From Pathophysiology to Novel Therapeutic Approaches (2nd Edition) (Deadline: 31 July 2024)
- Advances in Myocarditis: Molecular and Immune Mechanisms, Diagnosis and Treatment (Deadline: 31 July 2024)
- CAR-T Cell Therapy in Hematological Malignancies (Deadline: 31 July 2024)
- Molecular Targets for Biological Therapies of Severe Asthma: Second Edition (Deadline: 31 July 2024)
- Pathogenesis, Prophylaxis and Treatment of Infectious Diseases (Deadline: 31 July 2024)
- Mastocytosis, MCAS, and Related Disorders: From Mechanisms to Therapeutic Approaches (Deadline: 30 August 2024)
- Advanced Research in Secondary Immunodeficiency in Oncohematological Diseases (Deadline: 31 August 2024)
- Novel Biomarkers and Technologies in the Research and Diagnosis of Human Diseases (Deadline: 31 August 2024)
- Emerging Viral Infectious Diseases: Immunology, Therapeutics and Prevention in Post Pandemic Era (Deadline: 31 August 2024)
- Immunotherapy for Hepatocellular Carcinoma (Deadline: 31 August 2024)
- Inflammatory Bowel Diseases: New Diagnostic and Therapeutic Approaches (Deadline: 31 August 2024)
- Photodynamic Therapy (3rd Edition) (Deadline: 31 August 2024)
- Sepsis: Pathophysiology and Early Diagnostics (Deadline: 31 August 2024)
- PD-1/PD-L1 and Immunotherapy (Deadline: 31 August 2024)
- Pathomechanisms of Disturbances Underlying Chronic Disorders—2nd Edition (Deadline: 30 September 2024)
- Immune Mechanisms in Dermatology (Deadline: 30 September 2024)
- Diagnosis, Pathogenesis and Treatment of TAFRO Syndrome (Deadline: 30 September 2024)
- Tumor Immune Microenvironment and Novel Strategies for Cancer Immunotherapy (Deadline: 30 September 2024)
- Exploring Breakthroughs in Intestinal Mucosal Repair and Regeneration (Deadline: 30 September 2024)
- Renal Cell Carcinoma: From Pathophysiology to Novel Therapeutic Approaches (3rd Edition) (Deadline: 30 September 2024)
- Endothelial Dysfunction: From Pathophysiology to Novel Therapeutic Approaches 2.0 (Deadline: 30 September 2024)
Topical Collections
Following topical collections within this section are currently open for submissions:
